F. E. Kayhan Et Al. , "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension," Diabetes and Metabolic Syndrome: Clinical Research and Reviews , vol.7, no.1, pp.12-16, 2013
Kayhan, F. E. Et Al. 2013. Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension. Diabetes and Metabolic Syndrome: Clinical Research and Reviews , vol.7, no.1 , 12-16.
Kayhan, F. E., Koldemir, M., Çağatay, P., Çiftçi, P., & Süsleyici Duman, B., (2013). Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension. Diabetes and Metabolic Syndrome: Clinical Research and Reviews , vol.7, no.1, 12-16.
Kayhan, FİGEN Et Al. "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension," Diabetes and Metabolic Syndrome: Clinical Research and Reviews , vol.7, no.1, 12-16, 2013
Kayhan, FİGEN E. Et Al. "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension." Diabetes and Metabolic Syndrome: Clinical Research and Reviews , vol.7, no.1, pp.12-16, 2013
Kayhan, F. E. Et Al. (2013) . "Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension." Diabetes and Metabolic Syndrome: Clinical Research and Reviews , vol.7, no.1, pp.12-16.
@article{article, author={FİGEN ESİN KAYHAN Et Al. }, title={Prevalence of endothelial nitric oxide synthase E298D polymorphism in Turkish patients with essential hypertension}, journal={Diabetes and Metabolic Syndrome: Clinical Research and Reviews}, year=2013, pages={12-16} }